From: The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipients
Ethnicity
Expressers (*1/*1 + *1/*3)
Non-expressers (*3/*3)
Caucasian
4 (13 %)
30 (87 %)
East Asian
7 (44 %)
9 (66 %)*
South Asian
2 (40 %)
3 (60 %)
Black
2 (100 %)
0 (0 %)
Other
2 (66 %)
1 (33 %)